Expand ARCT Menu
ARCT MENU

ARCT Stock Posts


Unusual Option Volume

ARCT Arcturus Therapeutics Holdings14.03+0.73 (+5.5%)

Arcturus Therapeutics Holdings trades 2,320 contracts. The company has the following event: ROTH 5th Annual Healthcare Opportunities Conference on Sep 29, 2026. News: Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0 Next-Generation mRNA Delivery Platform
View Details...
Unusual Option Volume

ARCT Arcturus Therapeutics Holdings14.79-1.24 (-7.7%)

Arcturus Therapeutics Holdings trades 2,670 contracts. The company has the following event: Virtual Presentation on Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and mRNA Liver Therapeutics Platform Update on Sep 23, 2026.
View Details...
Unusual Option Volume

ARCT Arcturus Therapeutics Holdings13.28+2.29 (+20.8%)

Arcturus Therapeutics Holdings trades 2,211 contracts.
View Details...
Unusual Option Volume

ARCT Arcturus Therapeutics Holdings9.89+1.68 (+20.5%)

Arcturus Therapeutics Holdings trades 2,125 contracts. The highest volume is in the 21-Aug-26 10 calls, which is 1.1% above the current price.
View Details...
Unusual Option Volume

ARCT Arcturus Therapeutics Holdings7.49+1.41 (+23.2%)

Arcturus Therapeutics Holdings trades 2,872 contracts. The company has the following event: Canaccord Genuity 46th Annual Growth Conference on Aug 11, 2026. News: Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress
View Details...
Upcoming Earnings

ARCT Arcturus Therapeutics Holdings6.260.00 (0.0%)

Arcturus Therapeutics Holdings will report earnings after the market closes. View Calendar The market is expecting a ±13.5% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±9.9%. View Expected Move (Conf Call: Aug 6 4:30 PM)
Load Earlier Posts
Market Data Delayed 15 Minutes